Literature DB >> 9101400

Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus. Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus.

M Laakso1.   

Abstract

Lipid and lipoprotein abnormalities in non-insulin-dependent diabetes mellitus (NIDDM) include particularly elevated levels of total and very-low-density lipoprotein (VLDL) triglycerides and reduced levels of high-density lipoprotein (HDL) cholesterol. Total and low-density lipoprotein (LDL) cholesterol levels are usually normal if glycemic control is adequate. The worsening of glycemic control deteriorates lipid and lipoprotein abnormalities and particularly total and LDL cholesterol levels are often elevated in patients with poor glycemic control. According to prospective population-based studies total cholesterol is a powerful risk factor for coronary heart disease (CHD) in NIDDM patients as in nondiabetic subjects. In contrast, high total triglycerides and low HDL cholesterol may be even stronger risk factors for CHD in NIDDM patients than in nondiabetic individuals, but more prospective studies are needed to substantiate this view. Compositional changes in LDL and VLDL particles may further increase the risk for CHD but epidemiologic data are missing to support this notion. Preliminary data from the Scandinavian Simvastatin Survival Study including 202 diabetic patients seem to indicate that diabetic patients benefit from simvastatin treatment equally to nondiabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101400     DOI: 10.1016/s1056-8727(96)00092-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

1.  [Tackling lipaemia in diabetes mellitus in primary care].

Authors:  C Llor Vilà
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

2.  Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark.

Authors:  Lise Juul; Annelli Sandbaek; Anders Foldspang; Morten Frydenberg; Knut Borch-Johnsen; Torsten Lauritzen
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

Review 3.  Diabetes & coronary heart disease: current perspectives.

Authors:  Mohammed K Ali; K M Venkat Narayan; Nikhil Tandon
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

4.  Lipid profile of type 2 diabetic and hypertensive patients in the jamaican population.

Authors:  Lorenzo Gordon; Dalip Ragoobirsingh; Errol Y A Morrison; Eric Choo-Kang; Donovan McGrowder; E Martorell
Journal:  J Lab Physicians       Date:  2010-01

5.  Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Authors:  Rooh Ullah Khan; Mohammad Bashir
Journal:  Nutr J       Date:  2015-01-26       Impact factor: 3.271

6.  Vitamin C may have similar beneficial effects to Gemfibrozil on serum high-density lipoprotein-cholesterol in type 2 diabetic patients.

Authors:  Mansour Siavash; Masoud Amini
Journal:  J Res Pharm Pract       Date:  2014-07

7.  The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects.

Authors:  Saleem Ullah Shahid; Sumbal Sarwar
Journal:  Lipids Health Dis       Date:  2020-04-14       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.